Vitality Watch

⚠ Evidence note: Human outcome data on longevity interventions is limited; most claims rest on surrogate markers or animal models. Nothing here is medical advice.

Mentioned 2× · first seen 20-sep-2026 · last seen 07-oct-2026

Selenium and Selenoproteins

Current understanding

To be populated as evidence accumulates.

Evidence log

  • 2026-09-18 — Selenium Deficiency is a Significant Risk Factor for Sarcopenia: Evidence and Selenoprotein-Mediated Mechanisms.: Systematic review (2024-style narrative synthesis) consolidating epidemiological and clinical association data plus animal-model rescue studies concludes selenium deficiency is a dose-responsive risk factor for sarcopenia, with mechanistic mapping to GPX4 (ferroptosis defense), SELENOP (Se transport), SELENOW (redox in muscle), and SELENOT/N (ER Ca²⁺ and regeneration) — evidence remains observational + preclinical, no sarcopenia-endpoint RCT of Se supplementation. [human-observational] (novelty: 3)

Open questions

Related

Contributing findings

pubmed review human-observational
Selenium Deficiency is a Significant Risk Factor for Sarcopenia: Evidence and Selenoprotein-Mediated Mechanisms.
18-sep-2026 novelty 3 per-area 3 strengthens
pubmed review
Iron metabolism and ferroptosis in cardiovascular diseases: progress in the mechanism and pharmacological intervention.
29-jul-2026 novelty 2 per-area 1 mentions

build build 880 · 2bcef25 · 2026-11-18